Patients' ability to use a novel fluticasone propionate/formoterol breath-triggered inhaler (BTI) vs. budesonide/formoterol dry powder inhaler (DPI)

被引:1
作者
Bell, David [1 ]
Timmer, Wolfgang [2 ]
Mansfield, Lucielle [3 ]
Lomax, Mark [3 ]
Grothe, Birgit [3 ]
Overend, Tim [3 ]
机构
[1] BioKinet Europe Ltd, Belfast, Antrim, North Ireland
[2] Inamed GmbH, Gauting, Germany
[3] Mundipharma Res Ltd, Cambridge, England
关键词
D O I
10.1183/13993003.congress-2018.PA610
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
PA610
引用
收藏
页数:2
相关论文
empty
未找到相关数据